KoerselmanJVan der GraafJDe JaegerePPGrobbeeDECoronary collaterals: An important and underexposed aspect of coronary artery disease. Circulation2003;107:2507–11.
2.
BaroldiGManteroOScomazzoniG.The collaterals of the coronary arteries in normal and pathological hearts. Circ Res1956;4:223–9.
3.
ShaperW.Collateral circulation past and present. Basic Res Cardiol2009;104:5–21.
4.
SeilerC.The human coronary collateral circulation. Heart2003;89:1352–7.
5.
WernerGSFerrariMBetgeSCollateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation2001;104:2784.
6.
PohlTSeilerCBillingerMFrequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol2001;38:1872.
7.
SentiSFleischMBillingerMLong-term physical exercise and quantitatively assessed human collateral circulation. J Am Coll Cardiol1998;32:49.
8.
AbaciAOguzhanAKahramanSEffect of diabetes mellitus on formation of collateral vessels. Circulation1999;99:2239.
9.
WaltenbergerJLangeJKranzA.Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation2000;102:185.
10.
SchirmerSHVan NooijenFCPiekJJStimulation of coronary artery growth: Travelling further down the road to clinical application. Heart2009;95:191–7.
11.
SimonsMAnnexBHLahamRJPharmacological treatment of coronary artery disease with recombinant fibroblast growth factor: Double blind, randomized controlled clinical trial. Circulation2002;105:788–93.
12.
Van RoyenNSchirmerSHAtaseverBSTART trial: A pilot study on stimulation of arteriogenesis using subcutaneous application of granulocyte macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation2005;112:1040–6.
